Merck & Co Inc (NYSE:MRK)

72.54
BATS BZX Real-Time Price
As of 11:06am ET
 -0.31 / -0.43%
Today’s Change
65.25
Today|||52-Week Range
87.80
-11.32%
Year-to-Date
Stock Market News for Mar 3, 2021
9:31am / Zacks.com - Paid Partner Content
Merck to Assist J&J Vaccine; Target Beats in Q4
Mar 02 / Zacks.com - Paid Partner Content
Merck (MRK) to Help J&J Make COVID-19 Vaccine to Boost Supply
7:20am / Zacks.com - Paid Partner Content
Where Will Pfizer Be in 1 Year?
Mar 02 / MotleyFool.com - Paid Partner Content
AstraZeneca Just Sold Its Moderna Stock: Should You?
6:04am / MotleyFool.com - Paid Partner Content
Hillman Capital's Top 4 Buys of the 4th Quarter
Feb 26 / GuruFocus News - Paid Partner Content
Market Mood Swings: Buffett's Berkshire Reports 2020 Annual Earnings
Mar 02 / GuruFocus News - Paid Partner Content
Buy This Blue Chip on the Dip
Feb 26 / MotleyFool.com - Paid Partner Content
Wall Street Starts a Fresh Week at Record Highs
Mar 02 / Zacks.com - Paid Partner Content
Iovance (IOVA) Q4 Earnings Miss Estimates, Pipeline in Focus
Feb 26 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close72.85
Today’s open72.83
Day’s range72.42 - 73.43
Volume4,208,051
Average volume (3 months)9,632,639
Market cap$183.8B
Data as of 11:06am ET, 03/03/2021

Growth & Valuation

Earnings growth (last year)-27.21%
Earnings growth (this year)+9.09%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)+3.06%
P/E ratio26.1
Price/Sales4.33
Price/Book7.26

Competitors

 Today’s
change
Today’s
% change
PFEPfizer+0.36+1.07%
ABBVAbbVie-2.21-2.05%
LLYEli Lilly and Co-3.19-1.56%
NVSNovartis-0.86-0.98%
Data as of 11:06am ET, 03/03/2021

Financials

Next reporting dateApril 29, 2021
EPS forecast (this quarter)$1.63
Annual revenue (last year)$48.0B
Annual profit (last year)$7.1B
Net profit margin14.72%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Kenilworth, New Jersey

Forecasts